Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience – Page 962

Brilliant neurosurgeon Todd Mainprize found a new pathway to the brain

If Dr. Mainprize felt proud of his role in the breakthrough, he didn’t show it.

He was well aware of the significance of this achievement; it was potentially the key to tackling a wide range of illnesses, from brain cancer to Parkinson’s disease and Alzheimer’s disease – illnesses that are currently impossible or hard to cure. But he also knew he and his team at Sunnybrook Health Sciences Centre still had a long way to go before their work translated into actual treatment for patients, said his close friend and colleague Nir Lipsman.

Podcasts to Listen To: Future Thinkers and the best futurist podcasts to listen to

Nobody can predict what will happen in the future, but there are a few who are trying to help make sense of what is coming. Known as futurists, these “future” experts study the future and make predictions based on current trends. Here are a few futurist podcasts to help you make sense of where we are headed.

Future Thinkers

Created by Mike Gilliland and Euvie Ivanova, this podcast is focused on the evolution of society, technology and consciousness. Episodes include interviews with company founders, psychologists and philosophers. Recent episodes include “James Ehrlich — Regenerative Villages,” “Donald Hoffman — Do We See Reality As It Is?” and “Jamie Wheal Q&A.”

‘Where are my keys?’ and other memory-based choices probed in the brain

Summary: Study identifies a different set of individual neurons in the medial frontal cortex that is responsible for memory-based decision making. The findings have implications for the treatment of Alzheimer’s disease, schizophrenia, and other disorders associated with problems in cognitive flexibility.

Source: CalTech

Most of us know that feeling of trying to retrieve a memory that does not come right away. You might be watching a romantic comedy featuring that famous character actor who always plays the best friend and find yourself unable to recall her name (it’s Judy Greer). While memory retrieval has been the subject of countless animal studies and other neuroimaging work in humans, exactly how the process works–and how we make decisions based on memories–has remained unclear.

Single-gene treatment cures mice of Parkinson’s within three months

While there are ways to alleviate some symptoms, there is currently no way to prevent or cure Parkinson’s disease, so the prospect of a one-off treatment that completely eliminates it is certainly an exciting one. While such a therapy remains a while off, scientists have demonstrated an exciting proof of concept in mice, whereby inhibiting a single gene as a one-time treatment eradicated the disease entirely, and kept it at bay for the remainder of their lives.

The research was carried out at the University of California, San Diego (UCSD), and centers on a protein called PTB, which plays a role in which genes are switch on and off in a cell. The team was experimenting with techniques whereby the gene that encodes for PTB is switched off so researchers can determine the flow-on effects of a reduction in the that protein on other cell types, and found peculiar results when working with connective tissue cells called fibroblasts.

In one experiment, the team created a cell line that was permanently lacking PTB, and after a couple of weeks found that there was only a small amount of fibroblasts remaining in the dish, which was brimming with neurons instead. Building on this, the team was able to use a single treatment to inhibit the activity of PTB in mice, which reprogrammed support cells in the brain called astrocytes into neurons that produce the neurotransmitter dopamine.

One-Time Treatment Generates New Neurons, Eliminates Parkinson’s Disease in Mice

Xiang-Dong Fu, PhD, has never been more excited about something in his entire career. He has long studied the basic biology of RNA, a genetic cousin of DNA, and the proteins that bind it. But a single discovery has launched Fu into a completely new field: neuroscience.

For decades, Fu and his team at University of California San Diego School of Medicine studied a protein called PTB, which is well known for binding RNA and influencing which genes are turned “on” or “off” in a cell. To study the role of a protein like PTB, scientists often manipulate cells to reduce the amount of that protein, and then watch to see what happens.

But then he noticed something odd after a couple of weeks — there were very few fibroblasts left. Almost the whole dish was instead filled with neurons.

In this serendipitous way, the team discovered that inhibiting or deleting just a single gene, the gene that encodes PTB, transforms several types of mouse cells directly into neurons.

More recently, Fu and Hao Qian, PhD, another postdoctoral researcher in his lab, took the finding a big step forward, applying it in what could one day be a new therapeutic approach for Parkinson’s disease and other neurodegenerative diseases. Just a single treatment to inhibit PTB in mice converted native astrocytes, star-shaped support cells of the brain, into neurons that produce the neurotransmitter dopamine. As a result, the mice’s Parkinson’s disease symptoms disappeared.

Massive genomic database helps decode mutations’ effects

A trove of DNA sequences from 141,456 people — and counting — offers researchers an unparalleled look at genetic variation across the general population1,2. The resource has been helping researchers to identify variants that contribute to autism since it was released online about four years ago3,4.

The genomes of autistic people harbor hundreds of potentially harmful mutations. But to firmly connect a specific variant to the condition, researchers need to see if it is common among typical people — a sign that that variant may actually be benign.

In 2014, researchers debuted one of the first tools to probe the prevalence of a mutation in the general population. Known as the Exome Aggregation Consortium (ExAC), it contained 60,000 sequences of exomes — the protein-coding regions of the genome5.

Wireless Optogenetic Stimulation of Oxytocin Neurons in a Semi-natural Setup Dynamically Elevates Both Pro-social and Agonistic Behaviors

Complex behavioral phenotyping techniques are becoming more prevalent in the field of behavioral neuroscience, and thus methods for manipulating neuronal activity must be adapted to fit into such paradigms. Here, we present a head-mounted, magnetically activated device for wireless optogenetic manipulation that is compact, simple to construct, and suitable for use in group-living mice in an enriched semi-natural arena over several days. Using this device, we demonstrate that repeated activation of oxytocin neurons in male mice can have different effects on pro-social and agonistic behaviors, depending on the social context. Our findings support the social salience hypothesis of oxytocin and emphasize the importance of the environment in the study of social neuromodulators. Our wireless optogenetic device can be easily adapted for use in a variety of behavioral paradigms, which are normally hindered by tethered light delivery or a limited environment.

/* */